Ellington Management Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-11,200
| Closed | -$142K | – | 984 |
|
|
2018
Q1 | $142K | Buy |
+11,200
| New | +$142K | 0.01% | 751 |
|
|
2017
Q4 | – | Sell |
-17,700
| Closed | -$217K | – | 902 |
|
|
2017
Q3 | $217K | Buy |
+17,700
| New | +$217K | 0.04% | 494 |
|
|
2015
Q3 | – | Sell |
-7,610
| Closed | -$403K | – | 980 |
|
|
2015
Q2 | $403K | Buy |
+7,610
| New | +$403K | 0.1% | 319 |
|
|
2015
Q1 | – | Sell |
-15,200
| Closed | -$442K | – | 884 |
|
|
2014
Q4 | $442K | Buy |
+15,200
| New | +$442K | 0.15% | 232 |
|